The government's financial support for labor and delivery centers in vulnerable areas is not enough to increase the number of ...

The Ministry of Food and Drug Safety (MFDS) is examining whether to urgently introduce anakinra (Kineret in trademark name), ...

An international consensus statement outlining antiplatelet treatment strategies for East Asians has recently been ...

A research team at Seoul National University Bundang Hospital (SNUBH) has developed an artificial intelligence (AI) ...

Vetter, a leading, globally operating contract development and manufacturing organization (CDMO), celebrated the start of ...

Many people think that surgical scars are incurable, but this is not the case.Patients experience skin problems during cancer ...

A Seoul doctor who profited from administering psychotropic drugs to propofol addicts under the guise of cosmetic procedures ...

For a decade, CAR-T therapies such as Bristol Myers Squibb’s Abecma and Breyanzi, Gilead Sciences’ Yescarta and Tecartus, ...

With the recent reimbursement launch of Ebglyss (ingredient: lebrikizumab), a new biologic treatment developed by Eli Lilly, ...

Kuhnil Pharm has named former Takeda Korea General Manager Moon Hee-seok as its new co-CEO.Moon will oversee the company’s ...

Sydney’s Nepean Diagnostics, a private imaging center within Nepean Private Hospital, has become the beachhead for Coreline ...

Samsung Bioepis is handing its newest denosumab copycat, Xbryk, a biosimilar to Amgen’s bone cancer drug Xgeva, to longtime ...